Federal Judge invalidates Myriad’s DNA patent sequence claims

In the Southern District of New York on March 29, 2010, a District Court Judge rejected the prevailing opinion on the patentability of DNA sequences.  The Public Patent Foundation and the ACLU sued in 2009 to challenge certain claims in Myriad Genetics Inc.’s breast cancer patents (5,747,282, 5,837,492, 5,693,473, 5,709,999, 5,710,001, 5,753,441, 6,033,857). The plaintiffs